Andrew Hamer
Chief Tech/Sci/R&D Officer presso CARDIOL THERAPEUTICS INC.
Patrimonio netto: 433 278 $ in data 31/03/2024
Profilo
Andrew Hamer is currently the Chief Medical Officer and Head of Research & Development at Cardiol Therapeutics, Inc. Prior to this, he worked at Amgen, Inc. as the Executive Director of Global Development from 2018 to 2021.
He also held the position of Vice President of Medical Affairs at Capricor, Inc. and Capricor Therapeutics, Inc. from 2013 to 2015.
Dr. Hamer completed his undergraduate degree at the University of Otago.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 29/02/2024 | 239 380 ( 0.37% ) | 433 278 $ | 31/03/2024 |
Posizioni attive di Andrew Hamer
| Società | Posizione | Inizio |
|---|---|---|
| CARDIOL THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 29/03/2021 |
Precedenti posizioni note di Andrew Hamer
| Società | Posizione | Fine |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 01/03/2021 |
| CAPRICOR THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 30/07/2015 |
Capricor, Inc.
 Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a private company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Chief Tech/Sci/R&D Officer | - |
Formazione di Andrew Hamer
| University of Otago | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| CARDIOL THERAPEUTICS INC. | Health Technology |
| CAPRICOR THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a private company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Health Technology |
- Borsa valori
- Insiders
- Andrew Hamer
